Clinical trials: Chronic Blepharitis

Chronic Blepharitis

Demodex Blepharitis Treatment Study

• Completed
• Age: 15 to 80 years
• Phase 1
• Results posted

This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol (T4O), the most active ingredient of tea tree oil (TTO), in eradicating ocular demodicosis (reducing ocular demodex counts and achieving…

Trial name

DBTS (NCT01647217)

Testing

Terpinen-4-ol

Where

United States

Volunteers

17 people

Sponsor

BioTissue Holdings, Inc